Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
Alpha-Fetoprotein, or AFP – normally expressed during development and by liver cancer cells as well – has escaped attack in previous vaccine iterations because the body recognizes it as “self,” said Dr. Yukai He, immunologist at the Medical College of Georgia and Georgia Regents University Cancer Center.
Liver cancer is among the fastest-growing and deadliest cancers in the United States with a 17 percent three-year survival rate. Vaccines help direct the immune system to attack invaders by showing it a representative substance, called an antigen, that the body will recognize as foreign, in this case, AFP for liver cancer.
Read more . . .
The Latest on: Liver cancer
[google_news title=”” keyword=”Liver cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Liver cancer
- Burjeel Medical City carries out first deceased donor liver transplanton April 26, 2024 at 6:00 pm
The medical team at Burjeel Medical City (BMC) in Abu Dhabi, the flagship facility of Burjeel Holdings, performed a successful liver transplant surgery for a 66-year-old patient, thanks to a deceased ...
- Noninvasive liver cancer treatment now offered in Seattle's First Hill: HealthLinkon April 26, 2024 at 5:20 pm
The new treatment is called "Histotripsy" and uses ultrasound waves to target tumors and eliminates the need for patients to undergo surgery.
- Scientists discover a new signaling pathway and design a novel drug for liver fibrosison April 26, 2024 at 9:25 am
A healthy liver filters all the blood in your body, breaks down toxins and digests fats. It produces collagen to repair damaged cells when the liver is injured. However, a liver can produce too much ...
- Study identifies driver of liver cancer that could be target for treatmenton April 26, 2024 at 7:54 am
Metabolic diseases like obesity can increase the risk of developing liver cancer, research has shown. But how one disease predisposes to the other is unclear. In a new study, Yale researchers ...
- Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journalon April 25, 2024 at 4:00 am
Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today ...
- Pediatric cancer survivor becomes nurse, works with LVHN nurse who cared for heron April 25, 2024 at 2:02 am
A Lehigh Valley nurse and her former patient are back together again, but this time, they are both taking care of those who need them.
- Liver cancer: Molecular signaling pathway of tumor development decodedon April 23, 2024 at 5:00 pm
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain ...
- WOO Network trials investigate innovative treatments for liver, head and neck cancerson April 20, 2024 at 10:44 pm
A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different ...
- World Liver Day 2024: Expert explains the link between fatty liver and cancer riskon April 18, 2024 at 7:30 am
Most individuals with fatty liver disease may remain unaware of their condition until complications arise. Thus, health education plays a crucial role in identifying at-risk individuals and ...
- Signs and Symptoms of Liver Canceron April 18, 2024 at 5:00 am
Liver cancer causes cancer cells to grow out of control, causing symptoms like abdominal pain and swelling as the disease progresses to later stages.
via Bing News